Leukemia Research
Volume 33, Issue 12 , Pages 1664-1669 , December 2009

2-(1-Hydroxethyl)-4,8-dihydrobenzo[1,2-b:5,4-b′]dithiophene-4,8-dione (BTP-11) enhances the ATRA-induced differentiation in human leukemia HL-60 cells

  • Chun-Jen Chen

      Affiliations

    • Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan
    • ,
  • Yen-Fang Wen

      Affiliations

    • Pharmaceutical Technology Division, Biomedical Engineering Center, Industrial Technology Research Institute, Hsinchu, Taiwan
    • ,
  • Pi-Tsan Huang

      Affiliations

    • Pharmaceutical Technology Division, Biomedical Engineering Center, Industrial Technology Research Institute, Hsinchu, Taiwan
    • ,
  • Mei-Hua Hsu

      Affiliations

    • Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan
    • ,
  • Kuo-Hsiung Lee

      Affiliations

    • Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, USA
    • ,
  • Mei-Hwai Chen

      Affiliations

    • Pharmaceutical Technology Division, Biomedical Engineering Center, Industrial Technology Research Institute, Hsinchu, Taiwan
    • ,
  • Wuu-Chian Shin

      Affiliations

    • Pharmaceutical Technology Division, Biomedical Engineering Center, Industrial Technology Research Institute, Hsinchu, Taiwan
    • ,
  • Li-Jiau Huang

      Affiliations

    • Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan
    • ,
  • Sheng-Chu Kuo

      Affiliations

    • Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 4 22030760; fax: +886 4 22030760.

Received 20 January 2009 ,Revised 13 February 2009 ,Accepted 15 February 2009.

References 

  1. Bruserud O, Gjertsen BT. New strategies for the treatment of acute myelogenous leukemia: differentiation induction-present use and future possibilities. Stem Cells. 2000;18(3):157–165
  2. Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Haematol. 2001;38(1):13–25
  3. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood. 2000;95(1):90–95
  4. Gallagher RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia. 2002;16(10):1940–1958
  5. Shen ZX, Shi ZZ, Fang J, Gu BW, Li JM, Zhu YM, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.. PNAS. 2004;101(15):5328–5335
  6. Hassan HT, Zyada LE, Ragab MH, Rees JK. New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia. Eur J Clin Pharmacol. 1991;41(6):531–536
  7. Kosugi H, Towatari M, Hatano S, Kitamura K, Kiyoi H, Kinoshita T, et al. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia. 1999;13(9):1316–1340
  8. Kitamura K, Hoshi S, Koike M, Kiyoi H, Saito H, Naoe T. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. Br J Haematol. 2000;108(4):696–702
  9. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20(24):6969–6978
  10. Chao YH, Kuo SC, Wu CH, Lee CY, Mauger A, Sun IC, et al. Synthesis and cytotoxicity of 2-acetyl-4,8-dihydrobenzodithiophene-4, 8-dione derivatives. J Med Chem. 1998;41(23):4658–4661
  11. Chao YH, Kuo SC, Ku K, Chiu IP, Wu CH, Mauger A, et al. Synthesis and cytotoxicity of methyl-4,8-dihydrobenzo[1,2-b:5,4-b′]dithiophene-4,8-dione derivatives. Bioorg Med Chem. 1999;7(6):1025–1031
  12. Wen YF, Lee KH, Huang PT, Chen MH, Shin WC, Huang LJ, et al. Cell differentiation enhancement by hydrophilic derivatives of 4,8-dihydrobenzo [1,2-b:5,4-b′]dithiophene-4,8-diones in HL-60 leukemia cells. Bioorg Med Chem Lett. 2007;17(10):2908–2912
  13. Hung CY, Hsu MH, Huang LJ, Hwang CS, Lee O, Wu CY, et al. Synthesis of 1-substituted 3-pyridinyl-methylidenylindolin-2-ones and 1-substituted 3-quinolinylmethylidenylindolin-2-ones as the enhancers of ATRA-induced differentiation in HL-60 cells. Bioorg Med Chem. 2008;16:4222–4232
  14. Hsu MH, Kuo SC, Chen CJ, Chung JG, La YYi , Huang LJ. 1-(3,4-Dimethoxy-phenyl)-3,5-dodecenedione (I6) induces G1 arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Leukemia Res. 2005;29:1399–1406
  15. Chen CJ, Hsu MH, Huang LJ, Chung JG, Lee FY, Kuo SC. Anticancer mechanisms of YC-1 in human nonsmall-cell lung cancer cell line NCI-H226.. Biochem Pharmacol. 2008;75:360–368
  16. Brackman D, Lund-Johansen F, Aarskog D. Expression of leukocyte differentiation antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J Leukoc Biol. 1995;58(5):547–555
  17. Hmama Z, Nandan D, Sly L, Knutson KL, Herrera-Velit P, Reiner NE. 1 Alpha, 2,5-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med. 1999;190(11):1583–1594
  18. Walsh K, Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev. 1997;7(5):597–602
  19. Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH, et al. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood. 2001;97(1):264–269
  20. Ding Q, Jin T, Wang Z, Chen Y. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor gamma. J Leukoc Biol. 2007;81(6):1568–1576
  21. Park DJ, Chumakov AM, Vuong PT, Chih DY, Gombart AF, Miller WH, et al. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest. 1999;103(10):1399–1408
  22. Lekstrom-Himes JA. The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation. Stem Cells. 2001;19(2):125–133
  23. Truong BT, Lee YJ, Lodie TA, Park DJ, Perrotti D, Watanabe N, et al. CCAAT/enhancer binding proteins repress the leukemic phenotype of acute myeloidn leukemia. Blood. 2003;101(3):1141–1148

PII: S0145-2126(09)00099-X

doi: 10.1016/j.leukres.2009.02.023

Leukemia Research
Volume 33, Issue 12 , Pages 1664-1669 , December 2009

Article Tools

* Image Usage & Resolution